Mountain Crest Capital LLC is > 10% Shareholder of Better Therapeutics, Inc.. Currently has a direct ownership of 1.37 Million shares of BTTX, which is worth approximately $13,740. The most recent transaction as insider was on Apr 07, 2021, when has been sold 200,000 shares (Common Stock) at a price of $9.0 per share, resulting in proceeds of $1,800,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.37M
0% 3M change
0% 12M change
Total Value Held $13,740

Mountain Crest Capital LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 07 2021
SELL
Open market or private sale
$1,800,000 $9.0 p/Share
200,000 Reduced 12.71%
1,374,000 Common Stock
Jan 14 2021
BUY
Open market or private purchase
$75,000 $10.0 p/Share
7,500 Added 0.47%
1,574,000 Common Stock
Jan 12 2021
BUY
Open market or private purchase
$1,350,000 $10.0 p/Share
135,000 Added 7.93%
1,566,500 Common Stock
MCC

Mountain Crest Capital LLC

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on BTTX

Follow Better Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTTX shares.

Notify only if

Insider Trading

Get notified when an Better Therapeutics, Inc. insider buys or sells BTTX shares.

Notify only if

News

Receive news related to Better Therapeutics, Inc.

Track Activities on BTTX